DR patients may have hyperlipidemia associated with hyperglycemia that further increases Rac1–Nox2–ROS activation, causing progressive mitochondrial damage with the loss of capillary cells [73], cell apoptosis, inflammation, lipid peroxidation, and structural and functional alterations in the retina [71]. The gene discussed is CYBB; the disease is Hyperglycemia.